Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125727021 | 12572702 | 1 | I | 20160714 | 20160720 | 20160720 | EXP | CA-AMGEN-CANSP2016091924 | AMGEN | 40.00 | YR | A | M | Y | 0.00000 | 20160719 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125727021 | 12572702 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 125727021 | 12572702 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 125727021 | 12572702 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 125727021 | 12572702 | 4 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | UNK | 0 | ||||||||||
| 125727021 | 12572702 | 5 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 125727021 | 12572702 | 6 | SS | SECUKINUMAB | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QWK | 0 | 300 | MG | INJECTION | /wk | ||||||
| 125727021 | 12572702 | 7 | SS | SORIATANE | ACITRETIN | 1 | Unknown | UNK | 0 | CAPSULE | |||||||||
| 125727021 | 12572702 | 8 | SS | STELARA | USTEKINUMAB | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125727021 | 12572702 | 1 | Product used for unknown indication |
| 125727021 | 12572702 | 2 | Product used for unknown indication |
| 125727021 | 12572702 | 3 | Product used for unknown indication |
| 125727021 | 12572702 | 4 | Psoriasis |
| 125727021 | 12572702 | 5 | Product used for unknown indication |
| 125727021 | 12572702 | 6 | Psoriasis |
| 125727021 | 12572702 | 7 | Product used for unknown indication |
| 125727021 | 12572702 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125727021 | 12572702 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125727021 | 12572702 | Drug ineffective | |
| 125727021 | 12572702 | Headache | |
| 125727021 | 12572702 | Injection site haemorrhage | |
| 125727021 | 12572702 | Injection site swelling | |
| 125727021 | 12572702 | Insomnia | |
| 125727021 | 12572702 | Muscular weakness | |
| 125727021 | 12572702 | Myalgia | |
| 125727021 | 12572702 | Nausea | |
| 125727021 | 12572702 | Pain in extremity | |
| 125727021 | 12572702 | Psoriasis | |
| 125727021 | 12572702 | Vein rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |